AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 21 min read$SYK

BRAINERD MARY K purchased $27K of SYK (indirect holdings)

BRAINERD MARY K purchased 131 indirectly-held shares of STRYKER CORP (SYK) at an average of $204.09 ($185.65–$225.20) across 5 trades over 2019-06-26 to 2022-11-22.

Original reporting
SEC EDGAR · BRAINERD MARY K
Published Sep 2, 2026, 8:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 8:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$SYK
Neutral
high confidence
Mentioned
$SYK
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SYKNeutralLow
01

Why it matters

The disclosed purchase is unlikely to influence Stryker's share price or investor sentiment.

02

Market read

Low relevance; a routine insider purchase with minimal market impact.

03

What to watch

Potential future insider activity or upcoming board decisions could become relevant, but not evident now.

Relevance 4/10Novelty 4/10Timing: filed 2026-09-02

Background

Form 4 filings disclose insider transactions; this filing reports a director's modest purchase of Stryker shares.

Company-level read

Ticker impact

$SYKNeutralHigh confidence
Context

Director Mary K. Brainder purchased 131 shares of Stryker totaling $27K via open-market trades.

Expected impact

minimal to none

Evidence & confidence

Insider buying under $30K by a director is a routine disclosure with negligible market effect.

Market effects

Sector

None; the transaction does not affect the broader medical device sector.

Regional

None; limited to a single insider trade.

Global

None; no global market implications.

Counterpoint

What could challenge this read

Even small insider purchases can signal confidence, but the amount is too trivial to act on.

Key entities

  • Company
    Stryker Corp.

    Medical device manufacturer (ticker SYK).

  • Insider
    Mary K. Brainder

    Director of Stryker who made the purchase.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

SYK insider trading history →

Related articles

OCT 27
$SYKMed

Stryker completes ZuriMED takeover

Stryker has completed its acquisition of ZuriMED, adding the FiberLocker System for rotator cuff repair to its portfolio. The device, cleared by the FDA in 2024, is designed to reinforce the rotator cuff during or after shoulder repair. Stryker aims to expand its offerings in sports medicine and shoulder care, following strong growth in this segment.

finance.yahoo.com2 min
OCT 27
$GDMed

General Dynamics gets $136M to upgrade Stryker power system

General Dynamics Land Systems received a $135.9M contract modification from the U.S. Army to upgrade Stryker armored vehicles' power systems, increasing the total contract value to $162.4M. The contract, running until 2030, covers retrofit kits for existing Strykers, though specifics on quantities and timelines were not disclosed. General Dynamics was the sole bidder. This follows another $54.3M contract for Stryker maintenance and sustainment through 2031.

defence-blog.com2 min
OCT 26
$SYKHighAI 8/10

Stryker Closes ZuriMED Acquisition Adding Rotator Cuff Technology

Stryker completed its acquisition of privately held ZuriMED Technologies AG, adding the FiberLocker System to its Sports Medicine portfolio. The system, designed to strengthen rotator cuff repairs, received FDA clearance in 2024. Stryker aims to expand its shoulder care capabilities with this acquisition, though financial terms were not disclosed.

securities.io2 min